DK266889A - Doseringsformer med reguleret afgivelse med et bestemt vandindhold - Google Patents

Doseringsformer med reguleret afgivelse med et bestemt vandindhold Download PDF

Info

Publication number
DK266889A
DK266889A DK266889A DK266889A DK266889A DK 266889 A DK266889 A DK 266889A DK 266889 A DK266889 A DK 266889A DK 266889 A DK266889 A DK 266889A DK 266889 A DK266889 A DK 266889A
Authority
DK
Denmark
Prior art keywords
water content
dosage forms
particular water
regulated delivery
dosage form
Prior art date
Application number
DK266889A
Other languages
English (en)
Other versions
DK266889D0 (da
DK175130B1 (da
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antio Malkowska
Philip John Neale
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of DK266889D0 publication Critical patent/DK266889D0/da
Publication of DK266889A publication Critical patent/DK266889A/da
Application granted granted Critical
Publication of DK175130B1 publication Critical patent/DK175130B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198902668A 1988-06-02 1989-06-01 Doseringsformer med reguleret afgivelse med et bestemt vandindhold DK175130B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8813064 1988-06-02
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (3)

Publication Number Publication Date
DK266889D0 DK266889D0 (da) 1989-06-01
DK266889A true DK266889A (da) 1989-12-03
DK175130B1 DK175130B1 (da) 2004-06-14

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902668A DK175130B1 (da) 1988-06-02 1989-06-01 Doseringsformer med reguleret afgivelse med et bestemt vandindhold

Country Status (19)

Country Link
US (1) US5091189A (da)
EP (1) EP0344960B1 (da)
JP (1) JPH0816060B2 (da)
KR (1) KR0136279B1 (da)
AT (1) ATE83925T1 (da)
AU (1) AU610401B2 (da)
CA (1) CA1323834C (da)
DE (1) DE68904119T2 (da)
DK (1) DK175130B1 (da)
ES (1) ES2053989T3 (da)
FI (1) FI93695C (da)
GB (2) GB8813064D0 (da)
GR (1) GR3007088T3 (da)
IE (1) IE61998B1 (da)
IL (1) IL90462A (da)
NO (1) NO176232C (da)
NZ (1) NZ229372A (da)
PT (1) PT90722B (da)
ZA (1) ZA894201B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
TR200001942T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid agonist/antagonist kombinasyonlar
CN1204890C (zh) * 1997-12-22 2005-06-08 欧罗赛铁克股份有限公司 防止阿片样物质滥用的方法
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
SI2283842T1 (sl) * 2000-02-08 2015-07-31 Euro-Celtique S.A. Oralne formulacije opioidnih agonistov, varne pred zlorabo
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
DK1416842T3 (da) * 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
ES2326794T3 (es) 2001-08-06 2009-10-20 Euro-Celtique S.A. Formulaciones de agonistas opioides con antagonista liberable y secuestrado.
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IN192180B (da) * 2001-09-28 2004-03-06 Ranbaxy Lab
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
LT2425821T (lt) 2002-04-05 2017-07-25 Euro-Celtique S.A. Farmacinis preparatas, turintis oksikodono ir naloksono
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP2039349A1 (en) * 2004-10-19 2009-03-25 KRKA, tovarna zdravil, d.d., Novo mesto Solid pharmaceutical composition comprising donepezil hydrochloride
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
ZA200802602B (en) * 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
SI2484346T1 (sl) 2006-06-19 2017-05-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
BRPI0717149B1 (pt) * 2006-09-29 2016-02-16 Procter & Gamble composição oral contendo redes de gel e processo para o preparo da mesma.
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
SI2317991T1 (sl) * 2008-07-07 2017-09-29 Euro-Celtique S.A. Uporaba opioidnih antagonistov za zdravljenje retencije urina
PL2405915T3 (pl) 2009-03-10 2019-05-31 Euro Celtique Sa Kompozycje farmaceutyczne o natychmiastowym uwalnianiu zawierające oksykodon i nalokson
KR20160034352A (ko) 2013-07-23 2016-03-29 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
KR900000077A (ko) 1990-01-30
IE61998B1 (en) 1994-12-14
NO176232B (no) 1994-11-21
GB8911629D0 (en) 1989-07-05
EP0344960A3 (en) 1990-03-07
FI93695C (fi) 1995-05-26
IE891744L (en) 1989-12-02
IL90462A0 (en) 1990-01-18
DE68904119D1 (de) 1993-02-11
EP0344960A2 (en) 1989-12-06
AU610401B2 (en) 1991-05-16
NO176232C (no) 1995-03-01
ES2053989T3 (es) 1994-08-01
KR0136279B1 (ko) 1998-04-25
ZA894201B (en) 1990-03-28
NZ229372A (en) 1991-07-26
IL90462A (en) 1993-01-31
FI892664A0 (fi) 1989-06-01
ATE83925T1 (de) 1993-01-15
PT90722B (pt) 1994-11-30
DE68904119T2 (de) 1993-06-09
GB2219207B (en) 1992-01-02
GB2219207A (en) 1989-12-06
FI892664L (fi) 1989-12-03
NO892229D0 (no) 1989-06-01
NO892229L (no) 1989-12-04
DK266889D0 (da) 1989-06-01
US5091189A (en) 1992-02-25
CA1323834C (en) 1993-11-02
GB8813064D0 (en) 1988-07-06
FI93695B (fi) 1995-02-15
DK175130B1 (da) 2004-06-14
JPH0816060B2 (ja) 1996-02-21
AU3512789A (en) 1989-12-07
JPH0225420A (ja) 1990-01-26
PT90722A (pt) 1989-12-29
GR3007088T3 (da) 1993-07-30
EP0344960B1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DK266889D0 (da) Doseringsformer med reguleret afgivelse med et bestemt vandindhold
DK568687D0 (da) Hydromorphonpraeparat med reguleret afgivelse
DE68906477D1 (de) Zubereitungen mit verzoegerter freisetzung sowie deren herstellung.
DE3855852D1 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
MA21264A1 (fr) Composition permettant d'administrer un medicament sous forme de gellules, d'une poudre ou d'un liquide.
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
HUT49808A (en) Process for producing retarde pharmaceutical compositions containing aselastine
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DK0381220T3 (da) Vanddispergerbart gemfibrozilpræparat
ZA885372B (en) Nutrieut mixture intended for the elderly
GR3007347T3 (da)
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
EP0269452A3 (en) Use of ketone derivatives for the manufacture of medicaments
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
ES2052701T3 (es) Agente hipouricemico que contiene ponalrestat.
Kuczmann Behaviour of PVC Powder Grains Produced Using Suspension Technology, in Processing
FR2640506B1 (fr) Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente
Ritzman Nail biting explained.
IT8420829U1 (it) Dispositivo particolarmente per la regolazione dell'inclinazione laterale del gambale in scarponi da sci.

Legal Events

Date Code Title Description
PUP Patent expired